Department of Pediatric Oncology
Location: |
Černopolní 212/9, 662 63 Brno, Pavilion C
Černopolní 212/9, 662 63 Brno, Pavilion B2 Correspondence Address: Černopolní 212/9, 662 63 Brno |
---|
Phone: | +420 532 23 4755 |
---|---|
E-mail: | |
Total number of publications: 30
Articles
-
A computational workflow for analysis of missense mutations in precision oncology
JOURNAL OF CHEMINFORMATICS, year: 2024, volume: 16, edition: 1, DOI
-
A novel thrombocytopenia-4-causing CYCS gene variant decreases caspase activity: Three-generation study
British journal of haematology, year: 2024, DOI
-
ASO Author Reflections: The Effect of Local Adjuvants on Cortical Bone Following Intralesional Curettage of Bone Tumors
Annals of Surgical Oncology, year: 2024, volume: 31, edition: 9, DOI
-
Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study
JOURNAL OF CANCER SURVIVORSHIP, year: 2024, DOI
-
B cell subsets reconstitution and immunoglobulin levels in children and adolescents with B non-Hodgkin lymphoma after treatment with single anti CD20 agent dose included in chemotherapeutic protocols: single center and review of the literature
Biomedical Papers, Olomouc: Palacky University, year: 2024, volume: 168, edition: 2, DOI
-
CIC::NUTM1 sarcoma in a 6-year-old male patient arising from the choroid plexus of the lateral ventricle: A case report
PEDIATRIC BLOOD & CANCER, year: 2024, volume: 71, edition: 8, DOI
-
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study
Lancet Oncology, year: 2024, volume: 25, edition: 5, DOI
-
Dataset of DNA methylation profiles of 189 pediatric central nervous system, soft tissue, and bone tumors
Data in Brief, year: 2024, volume: 55, edition: August 2024, DOI
-
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors
American Journal of Hematology, year: 2024, volume: 99, edition: 4, DOI
-
Del(1p32) is an early and high-risk event in multiple myeloma patients with extraosseous disease
Blood Cancer Journal, year: 2024, volume: 14, edition: 1, DOI